Differentiation between the two types of amiodarone-associated thyrotoxicosis using duplex and amplitude doppler sonography

Acta Radiologica

Volumn 48, Issue 4, 2007, Pages 412-421

  Macedo, T A A ^a   Chammas, M C ^b   Jorge, P T ^b   Souza, L P ^b   Farage, L ^b   Watanabe, T ^b   Santos, V A ^b   Cerri, G G ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

Amiodarone; Duplex color Doppler ultrasonography; Iodine non deficient population; Thyroid vascularization; Thyrotoxicosis

Indexed keywords

BLOOD VESSELS; PARAMETER ESTIMATION; PATIENT TREATMENT; ULTRASONOGRAPHY;

AMIODARONE; DUPLEX-COLOR DOPPLER ULTRASONOGRAPHY; IODINE NON-DEFICIENT POPULATION; THYROID VASCULARIZATION; THYROTOXICOSIS;

DISEASES;

AMIODARONE; ANTIARRHYTHMIC AGENT;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD FLOW VELOCITY; CHEMICALLY INDUCED DISORDER; COLOR ULTRASOUND FLOWMETRY; DIFFERENTIAL DIAGNOSIS; DOPPLER ECHOGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART VENTRICLE EXTRASYSTOLE; HUMAN; IMAGE PROCESSING; MALE; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; PULSATILE FLOW; ROC CURVE; THYROID GLAND; THYROTOXICOSIS; VASCULAR RESISTANCE; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; AREA UNDER CURVE; ATRIAL FIBRILLATION; BLOOD FLOW VELOCITY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULSATILE FLOW; ROC CURVE; THYROID GLAND; THYROTOXICOSIS; ULTRASONOGRAPHY, DOPPLER, COLOR; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASCULAR RESISTANCE; VENTRICULAR PREMATURE COMPLEXES;

EID: 34247371018     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850701280791     Document Type: Article

References (22)

1. Bartalena L, Brogioni S, Grasso L, Velluzzi F, Martino E. Relationship of the increased serum interleukin-6 concentration to changes of thyroid function in nonthyroidal illness. J Endocrinol Invest 1994;17:269-74.
2. Bartalena L, Grasso L, Brogioni S, Aghini-Lombardi F, Braverman LE, Martino E. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 1994;78:423-7.
3. Bindra A, Braunstein GD. Thyroiditis. Am Fam Physician 2006;73:1769-76.
4. Bogazzi F, Bartalena L, Brogioni S, Mazzeo S, Vitti P, Burelli A, et al. Color flow Doppler sonography rapidly differentiates type 1 and type II amiodarone-induced thyrotoxicosis. Thyroid 1997;7:541-5.
5. Bogazzi F, Martino E, Dell'Unto E, Brogioni S, Cosci C, Aghini-Lombardi F, et al. Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis. J Endocrinol Invest 2003;26:635-40.
6. Bude RO, Rubin JM. Relationship between the resistance index and vascular compliance and resistance. Radiology 1999;211:411-7.
7. Daniels GH. Amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 2001;86:3-8.
8. Eaton SE, Euinton HA, Newman CM, Weetman AP, Bennet WM. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clin Endocrinol (Oxf) 2002;56:33-8.
9. Farwell AP, Braverman LE. Inflammatory thyroid disorders. Otolaryngol Clin North Am 1996;29:541-56.
10. Harjai KJ, Licata A A. Effects of amiodarone on thyroid function. Ann Intern Med 1997;126:63-73.
11. Martino E, Aghini-Lombardi F, Mariotti S, Bartalena L, Braverman L, Pinchera A. Amiodarone: a common source of iodine-induced thyrotoxicosis. Horm Res 1987;26:158-71.
12. Martino E, Bartalena L, Bogazzi F, Braverman LE. The effects of amiodarone on the thyroid. Endocr Rev 2001;22:240-54.
13. Morales AI, Barata JD, Bruges M, Arevalo MA, Gonzalez de Buitrago JM, Palma P, et al. Acute renal toxic effect of amiodarone in rats. Pharmacol Toxicol 2003;92:39-42.
14. Nademanee K, Piwonka RW, Singh BN, Hershman JM. Amiodarone and thyroid function. Prog Cardiovasc Dis 1989;31:427-37.
15. Newman CM, Price A, Davies DW, Gray TA, Weetman AP. Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart 1998;79:121-7.
16. Nikolai TF, Brosseau J, Kettrick MA, Roberts R, Beltaos E. Lymphocytic thyroiditis with spontaneously resolving hyperthyroidism (silent thyroiditis). Arch Intern Med 1980;140:478-82.
17. Pitcher WD. Amiodarone pulmonary toxicity. Am J Med Sci 1992;303:206-12.
18. Roti E, Uberti ED. Iodine excess and hyperthyroidism. Thyroid 2001;11:493-500.
19. Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000;342:913-20.
20. Sato K, Yamazaki K, Kanaji Y, Ohnishi S, Kasanuki H, Demura H. Amiodarone-induced thyrotoxicosis associated with thyrotropin receptor antibody. Thyroid 1998;8:1123-6.
21. Williams I, Ankrett VO, Lazarus JH, Volpe R. Aetiology of hyperthyroidism in Canada and Wales. J Epidemiol Community Health 1983;37:245-8.
22. Wong R, Cheung W, Stockigt JR, Topliss DJ. Heterogeneity of amiodarone-induced thyrotoxicosis: evaluation of colour-flow Doppler sonography in predicting therapeutic response. Intern Med J 2003;33: 420-6.